Korean J Prev Med.  1997 Mar;30(1):1-16.

A Case-Control Study on Association Between Hepatocellular Carcinoma and Infection of Hepatitis B and Hepatitis C Virus

Affiliations
  • 1Department of Preventive Medicine, College of Medicine, Korea University, Korea.
  • 2School of Public Health, Seoul National University, Korea.
  • 3Department of Family Medicine, Seoul Chung-Ang Hosipital, Korea.
  • 4School of Public Health, Seoul National University, Korea.

Abstract

To investigate the association between hepatocellular carcinoma(HCC) and infection of hepatitis B virus(HBV) and hepatitis C virus(HCV) in an HBV endemic area , a case-control study of 254 patients with HCC and of 1,270 age and sex matched health control subjects was done. Among the 254 HCC patients 166(65.4%) were positive for hepatitis B surface antigen(HBsAg), 49(19.3%) were positive for HCV antibody(anti-HCV Ab). The crude odd ratio of patients with HBsAg was 36.1(95% CI :22.4-58.2) and with anti-HCV Ab was 9.0(95% CI :5.5-14.6). In an analysis, which HBsAg(-), HBcAb(-), anti-HCV Ab(-) group was chosen as referent group, odd ratio of HBsAg(+) group was 14.4(95% CI: 7.2-28.9) and of anti- HCV Ab(+) was 10.7(95% CI: 2.9-40.0). Odd ratio of anti-HCV Ab(+), HBsAg(+) group and anti-HCV Ab(+), HBsAg(-), HBcAb(+) group for HCC were elevated to 27.3(95% CI : 9.0-82.9) , 15.9(95% CI:7.1-35.8) respectly. The odd ratio of anti-HCV Ab(-), HBsAg(-), HBcAb(+) group was 2.4(95% CI : 1.1-5.0). These result suggested that HBV and HCV were associated with HCC. In HBV endemic area patients with HBcAb alone should be considered risk group for HCC.

Keyword

Hepatocellular Carcinoma; Odd Ratio; Hepatitis B surface antigen; Hepatitis B core antibody; Hepatitis C antibody

MeSH Terms

Carcinoma, Hepatocellular*
Case-Control Studies*
Hepacivirus*
Hepatitis B Surface Antigens
Hepatitis B*
Hepatitis C*
Hepatitis*
Humans
Hepatitis B Surface Antigens
Full Text Links
  • KJPM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr